Panagora Asset Management Inc Syndax Pharmaceuticals Inc Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$18.82 - $23.79 $2.9 Million - $3.67 Million	-154,157 Reduced 65.04%	82,849 $1.7 Million
Q1 2024 May 07, 2024	BUY	$19.71 - $24.57 $1.24 Million - $1.54 Million	62,862 Added 36.1%	237,006 $5.64 Million
Q4 2023 Feb 08, 2024	BUY	$11.39 - $21.67 $941,326 - $1.79 Million	82,645 Added 90.32%	174,144 $3.76 Million
Q3 2023 Oct 31, 2023	SELL	$14.52 - $21.77 $2.55 Million - $3.82 Million	-175,583 Reduced 65.74%	91,499 $1.33 Million
Q2 2023 Aug 11, 2023	BUY	$19.35 - $22.31 $1.64 Million - $1.89 Million	84,701 Added 46.44%	267,082 $5.59 Million
Q1 2023 May 11, 2023	BUY	$20.66 - $28.98 $68,095 - $95,518	3,296 Added 1.84%	182,381 $3.85 Million
Q4 2022 Feb 13, 2023	BUY	$20.64 - $26.24 $2.28 Million - $2.89 Million	110,282 Added 160.29%	179,085 $4.56 Million
Q3 2022 Nov 14, 2022	SELL	$18.51 - $24.79 $2.55 Million - $3.42 Million	-138,015 Reduced 66.73%	68,803 $1.65 Million
Q2 2022 Aug 15, 2022	SELL	$13.64 - $19.48 $41,151 - $58,771	-3,017 Reduced 1.44%	206,818 $3.98 Million
Q1 2022 May 12, 2022	BUY	$14.84 - $22.15 $133,456 - $199,194	8,993 Added 4.48%	209,835 $3.65 Million
Q4 2021 Feb 10, 2022	SELL	$15.23 - $22.47 $50,852 - $75,027	-3,339 Reduced 1.64%	200,842 $4.4 Million
Q3 2021 Nov 10, 2021	SELL	$13.87 - $19.8 $25,243 - $36,036	-1,820 Reduced 0.88%	204,181 $3.9 Million
Q2 2021 Aug 11, 2021	BUY	$13.42 - $25.18 $1.12 Million - $2.1 Million	83,361 Added 67.97%	206,001 $3.54 Million
Q1 2021 May 12, 2021	BUY	$19.28 - $24.59 $237,741 - $303,219	12,331 Added 11.18%	122,640 $2.74 Million
Q4 2020 Feb 10, 2021	BUY	$15.1 - $26.44 $830,802 - $1.45 Million	55,020 Added 99.51%	110,309 $2.45 Million
Q3 2020 Nov 13, 2020	SELL	$13.39 - $17.48 $189,950 - $247,971	-14,186 Reduced 20.42%	55,289 $816,000
Q1 2020 May 14, 2020	SELL	$6.65 - $12.03 $412,326 - $745,908	-62,004 Reduced 47.16%	69,475 $761,000
Q4 2019 Feb 12, 2020	SELL	$5.43 - $9.22 $427,216 - $725,401	-78,677 Reduced 37.44%	131,479 $1.15 Million
Q3 2019 Nov 12, 2019	BUY	$7.47 - $10.76 $89,535 - $128,969	11,986 Added 6.05%	210,156 $1.57 Million
Q2 2019 Aug 09, 2019	BUY	$4.9 - $9.31 $245,147 - $465,779	50,030 Added 33.77%	198,170 $1.85 Million
Q1 2019 May 15, 2019	SELL	$4.26 - $6.86 $51,780 - $83,383	-12,155 Reduced 7.58%	148,140 $778,000
Q4 2018 Feb 14, 2019	BUY	$3.6 - $8.42 $13,615 - $31,844	3,782 Added 2.42%	160,295 $713,000
Q3 2018 Nov 13, 2018	BUY	$6.33 - $8.08 $437,592 - $558,570	69,130 Added 79.11%	156,513 $1.27 Million
Q2 2018 Aug 14, 2018	BUY	$6.93 - $14.63 $215,696 - $455,358	31,125 Added 55.33%	87,383 $613,000
Q1 2018 May 15, 2018	SELL	$8.71 - $14.82 $215,990 - $367,506	-24,798 Reduced 30.59%	56,258 $801,000
Q4 2017 Feb 14, 2018	BUY	$7.8 - $12.94 $632,236 - $1.05 Million	81,056	81,056 $710,000

Others Institutions Holding SNDX

# of Institutions

228

Shares Held

88.4M

Call Options Held

1.01M

Put Options Held

692K

Black Rock Inc. New York, NY

7.91M
Shares

$103 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

5.84M
Shares

$76.4 Million
9.23% of portfolio
Wellington Management Group LLP Boston, MA

4.99M
Shares

$65.2 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

4.89M
Shares

$63.9 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

4.11M
Shares

$53.7 Million
6.25% of portfolio

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $740M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account